12:00 AM
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Nanocort: Phase II started

Galapagos began a double-blind, Belgian and German Phase II trial to evaluate a single dose of 300 mg of IV Nanocort vs. 3 doses...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >